LECT2 and metabolic syndrome: Higher levels of LECT2 expression were present in participants with dyslipidemia and plasma LECT2 levels could be used as potential biomarker to differentiate the participants with dyslipidemia from those without dyslipidemia, accompanied by a sensitivity of 60.3%, specificity of 66.7%, based on the plasma cut‐off value at 16.5 ng/ml.28